Danaher Corporation Stock Fair Value Calculator – Analysts Forecast Double-Digit Earnings Growth for DHR (Danaher Corporation) in 2023
January 31, 2023
Trending News ☀️
Danaher Corporation Stock Fair Value Calculator – Danaher Corporation ($NYSE:DHR) (NYSE: DHR) is a diversified technology company that designs, manufactures, and markets innovative products and services. Analysts have recently predicted that Danaher Corporation’s earnings for Fiscal Year 2023 will grow at a double-digit rate. This prediction is based on the company’s successful track record of delivering consistent growth in revenues and profits since its inception. The company’s strong balance sheet and substantial cash reserves have also contributed to the positive outlook for its future. Danaher’s diversified portfolio of businesses, including Diagnostics, Life Sciences, Imaging and Informatics, and Environmental and Applied Solutions, provides it with numerous opportunities to capitalize on growth opportunities. The analysts’ expectations are further bolstered by Danaher’s commitment to research and development, which has enabled it to introduce several new products and services over the years.
Additionally, Danaher’s focus on operational efficiency and cost control has enabled it to maintain its competitive edge in the market. The company’s established relationships with key customers and partners have also helped it to remain competitive. Overall, analysts are optimistic that Danaher Corporation’s earnings for Fiscal Year 2023 will be strong and will provide a platform for future growth. With a strong balance sheet, robust cash reserves, and a diversified portfolio of businesses, Danaher is well-positioned to capitalize on potential growth opportunities.
Share Price
On Monday, DANAHER CORPORATION opened at $263.5 and closed at $262.8, down 1.2% from its prior closing price of $266.0. Despite this small dip, analysts have predicted double-digit earnings growth for the company in 2023. DANAHER CORPORATION is a global science and technology innovator, operating in various industries such as life sciences and diagnostics, environmental and applied solutions, and dental. This has largely been due to its success in the life sciences and diagnostics industry, where it develops and manufactures products for a range of medical applications. Analysts expect DANAHER CORPORATION to continue to perform well in the coming year as the economy recovers from the impact of the pandemic. The company’s strong product pipeline and its focus on innovation will likely drive earnings growth, with analysts forecasting double-digit growth in 2023.
DANAHER CORPORATION’s diversified business model is another factor that could contribute to its continued success. The company operates in a number of industries, which allows it to spread out its risk and reduce the impact of any single market downturn. This stability should help it achieve its projected earnings growth in 2023. The company’s diversified business, focus on innovation, and strong product pipeline should drive this growth, despite the recent dip in stock price. Investors should take note of these positive indicators as they look ahead to 2023. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Danaher Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 31.47k | 7.1k | 22.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Danaher Corporation. More…
| Operations | Investing | Financing |
| 8.52k | -2.23k | -2.57k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Danaher Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 84.35k | 34.26k | 64.55 |
Key Ratios Snapshot
Some of the financial key ratios for Danaher Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 20.7% | 38.5% | 27.0% |
| FCF Margin | ROE | ROA |
| 23.4% | 10.9% | 6.3% |
VI Analysis – Danaher Corporation Stock Fair Value Calculator
Our proprietary VI Line indicates that the fair value of DANAHER CORPORATION shares is around $287.0. At the current market price of $262.8, DANAHER CORPORATION shares are undervalued by 8.4%. Our analysis of DANAHER CORPORATION relies on a combination of industry and company-specific factors. We look at the company’s management team, product offerings, competitive position, financials, industry trends, and other metrics to assess its worth. We also consider the company’s balance sheet and cash flow to gauge its financial health. Using these tools, we can identify the opportunities and risks associated with investing in DANAHER CORPORATION. We then use our VI Line to determine the fair value of the stock, which serves as a baseline for investors to make informed decisions about their investments. With the VI app, investors can easily access a comprehensive analysis of DANAHER CORPORATION and make informed decisions about their investments. More…
VI Peers
Danaher Corp is a large company that operates in many different industries. Its main competitors are Abingdon Health PLC, Charles River Laboratories International Inc, and Dirui Industrial Co Ltd.
– Abingdon Health PLC ($LSE:ABDX)
Abingdon Health is a medical technology company that develops, manufactures, and markets diagnostic products and services for the early detection and monitoring of disease. The company has a market capitalization of 8.22 million as of 2022 and a return on equity of -39.58%. Abingdon Health’s products are used in a variety of settings, including primary care, hospitals, and clinics. The company’s products are designed to provide accurate and actionable information to clinicians to improve patient care and outcomes.
– Charles River Laboratories International Inc ($NYSE:CRL)
River Laboratories is a global provider of drug discovery, development and manufacturing services. The company has a market cap of $10.15 billion and a return on equity of 13.86%. River Laboratories offers a range of services to its clients, including preclinical and clinical research, manufacturing and packaging, and analytical testing. The company has a strong focus on quality and compliance, and works with clients to ensure that their products meet all regulatory requirements. River Laboratories is headquartered in Wilmington, Massachusetts.
– Dirui Industrial Co Ltd ($SZSE:300396)
Drui Industrial Co Ltd is a company that manufactures and sells medical devices. The company has a market cap of 6.61B as of 2022 and a ROE of 8.7%. The company’s products include medical equipment, such as X-ray machines, ultrasound machines, and CT scanners. The company also manufactures and sells medical supplies, such as gloves, gowns, and masks.
Summary
Analysts forecast that Danaher Corporation (DHR) will experience double-digit earnings growth in 2023. This is due to the company’s strong financial performance in the past few years and its ability to capitalize on industry trends. The company has a diverse portfolio of products and services, and it is well-positioned to benefit from the ongoing shift towards digitalization. Its core competencies of innovation, strategic acquisitions, and operational excellence are expected to continue to drive growth.
DHR is expected to benefit from increased demand for its products and services, as well as continued cost-cutting initiatives. Investors should keep an eye on the company’s progress and consider its stock as a potential buy.
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
